We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+16.15%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$63.6M
Cap. Flow
+$50.3M
Cap. Flow %
20.31%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
3
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$34.2M
2
MXCT icon
MaxCyte
MXCT
+$18M
3
NTRA icon
Natera
NTRA
+$8.33M
4
GH icon
Guardant Health
GH
+$7.41M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.52M

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$16.2M
2
CDNA icon
CareDx
CDNA
+$5.92M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
1
Guardant Health
GH
$21.9B
$52.7M 21.26%
978,445
+144,300
+17% +$7.41M
NTRA icon
2
Natera
NTRA
$46.9B
$48.4M 19.54%
1,104,581
+175,000
+19% +$8.33M
CTKB icon
3
Cytek Biosciences
CTKB
$611M
$30.9M 12.48%
2,100,000
– –
TWST icon
4
Twist Bioscience
TWST
$8.93B
$28.4M 11.45%
+805,000
New +$34.2M
ADPT icon
5
Adaptive Biotechnologies
ADPT
$4.07B
$25.6M 10.35%
3,600,434
+480,000
+15% +$4.52M
AKYA
6
DELISTED
Akoya BioSciences
AKYA
$24.7M 9.98%
2,104,785
– –
MXCT icon
7
MaxCyte
MXCT
$143M
$21M 8.46%
+3,225,000
New +$18M
TECH icon
8
Bio-Techne
TECH
$11.3B
$13.2M 5.33%
186,000
– –
SLGC
9
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.88M 1.16%
992,086
– –
BRKR icon
10
Bruker
BRKR
$8.94B
– –
-258,000
Closed -$16.2M
CDNA icon
11
CareDx
CDNA
$2.41B
– –
-275,551
Closed -$5.92M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Blue Water Life Science Advisors held 11 positions worth $248M, up 35% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors deployed $50.3M of net new capital in Q3 2022, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Twist Bioscience: 805,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Bruker, an estimated $16.2M sold.

  • Blue Water Life Science Advisors's largest Q3 2022 buy was Twist Bioscience: 805,000 shares worth $28.4M.
  • Blue Water Life Science Advisors added most to Natera in Q3 2022, an estimated $8.33M increase.
  • Blue Water Life Science Advisors fully exited Bruker in Q3 2022, selling an estimated $16.2M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $248M portfolio in Q3 2022.
  • Blue Water Life Science Advisors opened 2 new positions and closed 2 in Q3 2022.
  • Blue Water Life Science Advisors's portfolio value rose 35% quarter-over-quarter to $248M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.